scorecardresearch
Add as a preferred source on Google
Friday, January 30, 2026
TopicZydus Cadila

Topic: Zydus Cadila

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

India’s ZyCoV-D set to become world’s first DNA Covid vaccine as govt approval likely soon

Gujarat-based Zydus Cadila has told Modi govt that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next 10-12 days.

Zydus’s antiviral drug Virafin gets emergency approval to treat moderate Covid patients

In statement, Zydus Cadila says phase 3 clinical trial data showed Virafin reduced oxygen requirement in patients, & and that a significant number of them tested negative by 7th day.

On Camera

Economic Survey 2025-26 takes global lessons seriously—and shows why Swadeshi is the way to go

The Economic Survey 2025-26 is not a celebration of success, but a measured warning that the traditional paradigms of global economic growth are no longer applicable.

Economic Survey backs skilled visas to give IT services sector a boost, green energy for data centres

The IT services sector contributed more than half of India’s Gross Value Added, serving as a major driver of exports and employment, the Economic Survey 2025-26 has found.

Indian Army ties up with US drone company that made its name in the Ukraine conflict

Shield AI will provide V-BAT vertical takeoff & landing drones along with licences for software, which will be integrated into aircraft and made available to select Indian partners.

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.